The leader of a Park Forest church who had a cancerous part of his lung removed sang a hymn for his doctor at a follow-up ...
Healthcare Asia Magazine on MSN
Lung cancer surgery market set for $2.8b expansion by 2036 on rising cases
By region, India is emerging as the fastest-growing market, with a 7% CAGR. The global lung cancer surgery market is ...
Everyday Health on MSN
Side effects of lung cancer surgery and how to manage them
Side effects from lung cancer surgery can include pain, fatigue, cough, and shortness of breath. Discover what to expect after a lobectomy and tips to manage recovery at home.
According to the latest market analysis by Future Market Insights, the global lung cancer surgery market is entering a phase of steady, ...
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have found that adults ...
* Actual value in liters as % predicted not available. FEV 1: Forced expiratory volume in 1 s; Postop: Postoperation; Preop: Preoperation. There is a poor prognosis for lung cancer when surgery is not ...
Vertebral fractures — quantified using the spinal deformity index — were associated with lower percent predicted and absolute values of forced vital capacity (FVC) and total lung capacity (TLC) in ...
Objectives Investigate the correlation between the percentage of predicted forced expiratory volume in 1 s (FEV1%pred) and survival outcomes, namely relapse-free survival (RFS) and overall survival ...
Posts from this topic will be added to your daily email digest and your homepage feed. The most interesting thing about Markiplier’s horror flick is its journey from YouTube to the big screen. The ...
Dexmedetomidine, despite its wide-ranging benefits, may also pose a risk of delayed recovery in the postanesthesia care unit (PACU). Few studies have examined the relationship between dexmedetomidine ...
Mold is a silent threat, often going unnoticed as it quietly harms health. What's concerning is that exposure to mold during early childhood leaves its mark way into adolescence. In a study published ...
More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results